Changes

no edit summary
Line 268: Line 268:  
{| class="wikitable"
 
{| class="wikitable"
 
|-
 
|-
! ADULT TUMOR
+
! TUMOR
 
! SUBTYPES
 
! SUBTYPES
 
! BROAD ABERRATIONS (>10Mb)
 
! BROAD ABERRATIONS (>10Mb)
Line 300: Line 300:  
|Adults and pediatric tumors show similar CNVs; CDKN2A/CDKN2B loss may correlate with anaplastic histology  
 
|Adults and pediatric tumors show similar CNVs; CDKN2A/CDKN2B loss may correlate with anaplastic histology  
 
|PMID:23442159; PMID:28181325
 
|PMID:23442159; PMID:28181325
 +
|-
 +
|
 +
|Ganglioglioma
 +
|'''Gain:''' polysomy 5, polysomy 7, 10p<br>
 +
'''Loss:''' 1p loss, monosomy (with focal CDKN2A loss)
 +
|'''Mutation:''' BRAF V600E , TSC1, TSC2, FGFR1, FGFR2, KRAS
 +
|Generally indolent tumors; surgical resection can be curative
 +
|PMID:23442159; PMID:25764012; PMID:29880043
 +
|-
 +
|
 +
|Angiocentric glioma
 +
|'''Loss:''' 6q24-q25
 +
|'''Fusion:''' MYB-QKI rearrangement/deletion (classic histology)<br>
 +
'''Rearrangement:''' MYB alone (atypical histology)<br>
 +
'''Amplification:''' MYB (atypical histology)
 +
|Generally indolent tumors; surgical resection can be curative
 +
|PMID:26829751
 +
|-
 +
|
 +
|Dysembryoplastic neuroepithelial tumor (DNET)
 +
|No specific changes
 +
|'''Mutation:''' intragenic duplication or mutation FGFR1; BRAF V600E
 +
|Rare in adults; Benign with excellent prognosis even with subtotal resection
 +
|PMID:26920151; PMID:23442159; PMID:21937911
 +
|-
 +
|
 +
|Rosette forming glioneuronal tumor
 +
|'''Gain:'''1q , 7, 9, 16<br>
 +
'''Loss:''' 1p<br>
 +
'''Amplification:''' 9q34.2, 19p13.3
 +
|'''Fusion:''' KIAA1549-BRAF fusion (via 3'BRAF duplication)<br>
 +
'''Mutation:''' PIK3CA, FGFR1<br>
 +
'''Amplification:''' SBNO2
 +
|Generally indolent tumors; surgical resection can be curative
 +
|PMID:27893178; PMID:26371886
 +
|-
 +
|Infiltrating Gliomas
 +
|-